Depression and functional status are strongly associated with dyspnea in interstitial lung disease.

  title={Depression and functional status are strongly associated with dyspnea in interstitial lung disease.},
  author={Christopher J. Ryerson and Jane Berkeley and Virginia Carrieri-Kohlman and Steven Z. Pantilat and C. Seth Landefeld and Harold R. Collard},
  volume={139 3},
BACKGROUND Little is understood about the characteristics of dyspnea in patients with interstitial lung disease (ILD), and its severity is likely influenced by multiple factors. Depression and functional status are known to influence dyspnea in patients with COPD. The aim of this study was to determine the relationship of dyspnea with clinical parameters, including depression and functional status, in patients with ILD. METHODS Dyspnea was measured with the Baseline Dyspnea Index and the… 

Tables from this paper

Dyspnea on Exercise Is Associated with Overall Symptom Burden in Patients with Chronic Respiratory Insufficiency

Patients with chronic respiratory insufficiency need comprehensive symptom screening with relevant treatment, as they suffer from broad symptom burden worsening with increased dyspnea on exercise.

Psycho-Physiological Associates of Dyspnea in Hospitalized Patients with Interstitial Lung Diseases: A Cross-Sectional Study

  • Y. ZhouY. Mak
  • Medicine, Psychology
    International journal of environmental research and public health
  • 2017
Respiratory rehabilitation with an appropriate intensity of exercise training or other strategies for enhancing the physical functioning of this population with moderate and severe levels of dyspnea should be prioritized.

Depression Is Significantly Associated with the Health Status in Patients with Idiopathic Pulmonary Fibrosis

Depression was a significant determinant of the HRQOL or health status in patients with IPF, and was selected as independent determinants of the total SGRQ score.

Dyspnea is associated with overall symptom burden in patients with chronic respiratory insufficiency

Patients with chronic respiratory insufficiency need comprehensive symptom screening with relevant treatment, as they suffer from many severe symptoms worsening with increased dyspnea.

Clinical impact of depression and anxiety in patients with idiopathic pulmonary fibrosis

Depression and anxiety are relatively common in patients with idiopathic pulmonary fibrosis and the present study suggests that depression and anxiety significantly influence quality of life in Patients with IPF.

An Observational Study of Anxiety and Depression in Idiopathic Pulmonary Fibrosis

Anxiety and depression are highly prevalent in IPF and are associated with severe and progressive disease, and increasing symptom burden is associated with worsening mental health.

Are Idiopathic Pulmonary Fibrosis Patients more Anxious and Depressive than Patient’s with Other Interstitial Lung Disease?

This study investigated whether anxiety depression in IPF was more frequent than other ILDs and its effect on quality of life and led to the conclusion that anxiety depression should also be evaluated in non-IPF ILD patients.


Disease severity and consequently functional performance were significantly correlated with depression, while age, smoking index, duration since diagnosis and number of therapies were not significantly correlated.

Detecting anxiety and depression in patients diagnosed with an interstitial lung disease. Can we do better?

It is reported that MRC score is an independent predictor of anxiety and depression in a mixed ILD cohort, and the opportunity for the early detection of depression in primary or secondary care in patients diagnosed with ILD continues to be missed.



Associations of depressive symptoms with gender, body mass index and dyspnea in primary care COPD patients.

It is suggested that in primary care depressive symptoms in COPD seem to be related with female gender, BMI and dyspnea, and lung function, exacerbation rate, smoking behaviour, age and comorbidity are not independently associated with depressive symptoms.

Quality of life of idiopathic pulmonary fibrosis patients.

Rehabilitation programmes are needed that are aimed at physiological aspects and psychosocial aspects of idiopathic pulmonary fibrosis in order to enhance the quality of life of these patients.

The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes.

The results indicate that dyspnea can receive a direct clinical rating that provides important information not disclosed by customary physiologic tests.

Combined effects of obesity and chronic obstructive pulmonary disease on dyspnea and exercise tolerance.

The combined mechanical effects of obesity and COPD reduced operating lung volumes at rest and throughout exercise with favorable influences on dyspnea perception and peak oxygen uptake during cycle ergometry.

BODE index versus GOLD classification for explaining anxious and depressive symptoms in patients with COPD – a cross-sectional study

The BODE index is superior to the GOLD classification for explaining anxious and depressive symptoms in COPD patients and these psychological consequences of the disease may play a role in future classification systems of COPD.

Dyspnea in interstitial lung disease

Dyspnea remains a common and difficult to treat symptom for people with interstitial lung disease, and aggressive treatment of physical and psychiatric comorbidities is important.

Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality.

The hypothesis that the critical pathway to end-stage fibrosis is not "alveolitis" but rather the ongoing epithelial damage and repair process associated with persistent fibroblastic proliferation is supported.

Body mass index and mortality in patients with idiopathic pulmonary fibrosis.

Higher BMI was associated with better survival in patients with IPF and was significantly associated with BMI in a proportional hazards regression model.